Neptune Medical key facts
- Developer of a novel gastroenterology device designed to assist in diagnosing and treating small intestine diseases.
- Neptune Medical’s last known valuation is $387.0M.
- It has raised $190.5M; the latest was Later Stage VC ($97.0M) in Aug 2024.
- Notable investors include InterVest, Johnson & Johnson JJDC, LB Investment, ShangBay Capital, Invus Opportunities — 15 tracked in total.
- Status: Privately Held (backing).
Who backs Neptune Medical
15+- ·The complete investor list: 15 names
- ·Watch Neptune Medical: the Monday email on marks, rounds and moves
Neptune Medical funding rounds
No funding rounds for Neptune Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Neptune Medical valuation
Neptune Medical's last known valuation is $387 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Neptune Medical investors
15 investors are on record for Neptune Medical, including InterVest, Johnson & Johnson JJDC, LB Investment and ShangBay Capital. By type, the record holds 6 venture capital firms.
About Neptune Medical
Developer of a novel gastroenterology device designed to assist in diagnosing and treating small intestine diseases. The company's device offers tip control in any anatomy, allowing the endoscope scope tip to move forward and torque as needed, and remain in place with an open lumen to swap or reinsert scopes without kinks and luminal collapse, enabling doctors to speed up procedures, reduce anesthesia time, and improve patient comfort.
- Sector
- Healthcare
- HQ
- Burlingame, CA, United States
- Founded
- 2014
- Employees
- 143
- Website
- gipathfinder.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Neptune Medical’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.